• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AKR1B10作为2型麻风反应生物标志物和治疗靶点的潜力。

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction.

作者信息

Soares Cleverson T, Fachin Luciana R V, Trombone Ana P F, Rosa Patricia S, Ghidella Cássio C, Belone Andrea F F

机构信息

Department of Anatomic Pathology, Instituto Lauro de Souza Lima, Bauru, Brazil.

Department of Health Science, Universidade do Sagrado Coração, Bauru, Brazil.

出版信息

Front Med (Lausanne). 2018 Sep 24;5:263. doi: 10.3389/fmed.2018.00263. eCollection 2018.

DOI:10.3389/fmed.2018.00263
PMID:30320113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6166685/
Abstract

The (aldo-keto reductase family 1 member B10) gene has important functions in carcinogen-induced neoplasia. AKR1B10 is also expressed in type 2 reaction leprosy patients (R2). We measured the expression of AKR1B10 in the skin lesions of patients with leprosy by immunohistochemistry from biopsies that encompassed the spectrum of types of leprosy, based on the Ridley and Jopling classification [10 samples each of tuberculoid (TT), borderline tuberculoid (BT), mid-borderline (BB), and borderline lepromatous (BL) lesions; four samples of lepromatous lesions (LL)], reactional leprosy [14 samples of type 1 Reaction (R1) and 10 samples of type 2 Reaction (R2)], and biopsies from 9 healthy control (HC) subjects. In addition, 46 lepromatous lesions (BL and LL), 45 lepromatous lesions in regression, and 115 R2 lesions were included. Eight of 10 R2 samples (80%), 3 of 46 active BL and LL samples (6%), 23 of 45 BL and LL samples in regression (51%), and 107 of 115 R2 samples (93%) were positive for AKR1B10, differing significantly between all groups ( < 0.05). AKR1B10 expression was highest in the cytoplasm of macrophages. Thus, AKR1B10 is overexpressed on the lepromatous side (BL and LL) in samples that are in regression, especially type 2 reaction-associated lesions, rendering it a potential marker of type 2 reactional episodes of leprosy and a target of drugs against reactional episodes.

摘要

醛酮还原酶家族1成员B10(AKR1B10)基因在致癌物诱导的肿瘤形成中具有重要作用。AKR1B10在2型麻风反应患者(R2)中也有表达。我们根据里德利和乔普林分类法,通过免疫组织化学方法检测了涵盖各种麻风类型活检样本中麻风患者皮肤病变中AKR1B10的表达情况[结核样型(TT)、界线结核样型(BT)、中间界线型(BB)和界线类偏瘤型(BL)病变各10份样本;瘤型病变(LL)4份样本]、麻风反应[1型反应(R1)14份样本和2型反应(R2)10份样本],以及9名健康对照(HC)受试者的活检样本。此外,还纳入了46份瘤型病变(BL和LL)、45份消退期瘤型病变以及115份R2病变样本。10份R2样本中的8份(80%)、46份活跃的BL和LL样本中的3份(6%)、45份BL和LL消退期样本中的23份(51%)以及115份R2样本中的107份(93%)AKR1B10呈阳性,所有组之间差异有统计学意义(P<0.05)。AKR1B10在巨噬细胞胞质中表达最高。因此,AKR1B10在消退期样本的瘤型侧(BL和LL)尤其是与2型反应相关的病变中过度表达,使其成为麻风2型反应发作的潜在标志物以及针对反应发作的药物靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/f3ffc44e420e/fmed-05-00263-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/90fdfb40e7f1/fmed-05-00263-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/8111105aa471/fmed-05-00263-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/6c2dc49201f7/fmed-05-00263-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/f3ffc44e420e/fmed-05-00263-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/90fdfb40e7f1/fmed-05-00263-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/8111105aa471/fmed-05-00263-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/6c2dc49201f7/fmed-05-00263-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d55/6166685/f3ffc44e420e/fmed-05-00263-g0004.jpg

相似文献

1
Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction.AKR1B10作为2型麻风反应生物标志物和治疗靶点的潜力。
Front Med (Lausanne). 2018 Sep 24;5:263. doi: 10.3389/fmed.2018.00263. eCollection 2018.
2
Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.麻风病中红细胞超氧化物歧化酶、过氧化氢酶活性及过氧化氢诱导的脂质过氧化作用
Lepr Rev. 2007 Dec;78(4):391-7.
3
Clinical and histopathological correlation in the classification of leprosy.麻风病分类中的临床与组织病理学相关性
Int J Lepr Other Mycobact Dis. 1993 Sep;61(3):433-8.
4
Immunohistochemical assessment of cell populations in leprosy-spectrum lesions and reactional forms.麻风光谱病变和反应性形式中细胞群体的免疫组织化学评估。
Histol Histopathol. 2017 Apr;32(4):385-396. doi: 10.14670/HH-11-804. Epub 2016 Jul 22.
5
Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.麻风病患者红细胞谷胱甘肽过氧化物酶、谷胱甘肽还原酶活性及血液谷胱甘肽含量
J Infect. 2008 Jun;56(6):469-73. doi: 10.1016/j.jinf.2008.03.009. Epub 2008 Apr 25.
6
Differential Expression of MicroRNAs in Leprosy Skin Lesions.麻风病皮肤病变中微小RNA的差异表达
Front Immunol. 2017 Aug 25;8:1035. doi: 10.3389/fimmu.2017.01035. eCollection 2017.
7
Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.结核样型和瘤型麻风反应性损害中主要T细胞表型及分布模式的差异。
Clin Exp Immunol. 1984 Mar;55(3):623-8.
8
Correlation of Clinico-pathological Classification of Hansen's Disease in a South Indian City.印度南部一座城市中麻风病临床病理分类的相关性
Indian J Lepr. 2014 Oct-Dec;86(4):147-54.
9
Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.调节性T细胞与Th17细胞之间的相互作用:与麻风病中极化免疫的相关性
PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004338. doi: 10.1371/journal.pntd.0004338. eCollection 2016 Jan.
10
Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.麻风病患者细胞介导免疫的预后评估及其与麻风病临床病理状态的相关性
Indian J Pathol Microbiol. 1996 Jan;39(1):5-12.

引用本文的文献

1
The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer.醛酮还原酶1B10的泛癌图谱显示,其在胃癌中的表达降低。
Front Immunol. 2024 Dec 6;15:1488042. doi: 10.3389/fimmu.2024.1488042. eCollection 2024.
2
Aldo-keto reductase family 1 member B10 prevents esophageal squamous cell carcinoma from reactive carbonyl species-induced cell death and promotes its progression.醛酮还原酶家族1成员B10可防止食管鳞状细胞癌因活性羰基化合物诱导的细胞死亡,并促进其进展。
Cancer Cell Int. 2024 Dec 22;24(1):425. doi: 10.1186/s12935-024-03623-8.
3
The Role of AKR1B10 in Lung Cancer Malignancy Induced by Sublethal Doses of Chemotherapeutic Drugs.

本文引用的文献

1
Differential Expression of MicroRNAs in Leprosy Skin Lesions.麻风病皮肤病变中微小RNA的差异表达
Front Immunol. 2017 Aug 25;8:1035. doi: 10.3389/fimmu.2017.01035. eCollection 2017.
2
AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.醛酮还原酶1B10通过激活细胞外信号调节激酶信号通路促进乳腺癌细胞的迁移和侵袭。
Oncotarget. 2017 May 16;8(20):33694-33703. doi: 10.18632/oncotarget.16624.
3
Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
AKR1B10在亚致死剂量化疗药物诱导的肺癌恶性肿瘤中的作用
Cancers (Basel). 2024 Jul 1;16(13):2428. doi: 10.3390/cancers16132428.
4
Leprosy: treatment, prevention, immune response and gene function.麻风病:治疗、预防、免疫应答和基因功能。
Front Immunol. 2024 Feb 19;15:1298749. doi: 10.3389/fimmu.2024.1298749. eCollection 2024.
5
Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines.肾细胞癌Caki细胞系中NRF2信号通路的差异激活
Biomedicines. 2023 Mar 24;11(4):1010. doi: 10.3390/biomedicines11041010.
6
AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study.AKR1B10作为一种潜在的新型乳腺癌血清生物标志物:一项初步研究。
Front Oncol. 2022 Feb 24;12:727505. doi: 10.3389/fonc.2022.727505. eCollection 2022.
7
The Role of AKR1B10 in Physiology and Pathophysiology.醛糖还原酶1B10(AKR1B10)在生理和病理生理中的作用
Metabolites. 2021 May 21;11(6):332. doi: 10.3390/metabo11060332.
8
Insights into Proteomics and Biomarkers-An Overview.蛋白质组学与生物标志物洞察——概述
Proteomes. 2021 Jan 29;9(1):7. doi: 10.3390/proteomes9010007.
9
Advances in the Immunology and Genetics of Leprosy.麻风病免疫学与遗传学进展
Front Immunol. 2020 Apr 16;11:567. doi: 10.3389/fimmu.2020.00567. eCollection 2020.
乳腺癌细胞获得蒽环类药物耐药性后雌激素信号通路的改变。
PLoS One. 2017 Feb 14;12(2):e0172244. doi: 10.1371/journal.pone.0172244. eCollection 2017.
4
Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.醛酮还原酶(AKR1B1和AKR1B10)在人类乳腺癌中的过表达及比活性增强
Breast. 2017 Feb;31:137-143. doi: 10.1016/j.breast.2016.11.003. Epub 2016 Nov 14.
5
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.治疗前AKR1B10表达可预测丙型肝炎病毒根除后肝细胞癌发生风险。
World J Gastroenterol. 2016 Sep 7;22(33):7569-78. doi: 10.3748/wjg.v22.i33.7569.
6
Global leprosy update, 2015: time for action, accountability and inclusion.《2015年全球麻风病最新情况:采取行动、承担责任与包容的时候了》
Wkly Epidemiol Rec. 2015 Sep 2;91(35):405-20.
7
Immunohistochemical assessment of cell populations in leprosy-spectrum lesions and reactional forms.麻风光谱病变和反应性形式中细胞群体的免疫组织化学评估。
Histol Histopathol. 2017 Apr;32(4):385-396. doi: 10.14670/HH-11-804. Epub 2016 Jul 22.
8
Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.醛酮还原酶1B10通过下调过氧化物酶体增殖物激活受体γ依赖性机制促进胃肠道癌细胞顺铂耐药性的发展。
Chem Biol Interact. 2016 Aug 25;256:142-53. doi: 10.1016/j.cbi.2016.07.008. Epub 2016 Jul 11.
9
Corticosteroids for treating nerve damage in leprosy.用于治疗麻风病神经损伤的皮质类固醇。
Cochrane Database Syst Rev. 2016 May 23;2016(5):CD005491. doi: 10.1002/14651858.CD005491.pub3.
10
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.醛酮还原酶家族1成员B10抑制剂:癌症治疗的潜在药物。
Recent Pat Anticancer Drug Discov. 2016;11(2):184-96. doi: 10.2174/1574892811888160304113346.